iwCLL offers two fellowships for early to mid-career hematologists, scientists or other professional career in biomedical research working on CLL in non-high-income countries (*). The fellowship will enable you to spend three months training in CLL in collaboration with a CLL Investigator in a Center that has a proven track record in diagnosis and management of patients with CLL and in CLL translational research in a high-income country and/or to pursue a research project.
(*) LMIC ‘s (ODA) updated country income classifications are available here.
Level of funding
The maximum amount awarded will be 10,000 USD per fellowship. The fellowship amount will be determined by the cost of the project and the duration of the fellowship.
Duration of fellowship
Scope of the project
iwCLL is looking to support projects focused on either research, laboratory or clinical management, however, emphasis should be on how the proposed project would benefit CLL care/CLL research in your home country.
Examples of supported projects include, but are not limited to:
- Learn and implement in your home country technology relevant to CLL diagnosis, prognosis or measurement of treatment outcome (i.e. flow cytometry, MRD, FISH, TP53 mutation testing)
- Develop and carry out a feasible clinical trial in your home country with results relevant to care setting in home country
- Research projects to better characterize any aspect of CLL in your home country.
Eligibility and suitability
- Early to mid-career hematologists, scientists or other professional career in biomedical research from non-high-income countries working in CLL.
- Based in a non-high-income country with a proposed project that would benefit CLL care/CLL research in your home country.
- Demonstrated commitment to scholarship and/or to improving access to CLL care/CLL research in your home country.
- To be a future opinion leader at your institution with an institutional commitment to their career
How to apply
Please apply through our on-line application formApplication form
What your application should include:
- Your CV
- One page statement of your career aspirations, including how this fellowship would help to improve CLL care/CLL research in your home country.
- Three-page proposal of your planned project during the fellowship, including expected endpoints/outcomes and ethical issues if applied.
- Letter of support including training plan, from proposed supervisor/collaborator at the CLL Center of Excellence.
- Letter of support of the local mentor/supervisor from your home country
- Two additional letters of recommendation
Evaluation and selection process
Applications will be reviewed by members of the iwCLL Global Partnerships Subcommittee especially by regional representatives of the subcommittee to assess the relevance of the project in the corresponding region, their decision will be ratified by the iwCLL Executive Board.
We will assess your proposal on various aspects including evaluation criteria of the project as outlined below, the track record of the main proposer, how well the project aligns with the capabilities of the team doing the project and the strength of the institution providing support for the project.
Applications which are outside the scope of the opportunity will not be assessed.
The scoring template used to review the applications will be as follows:
RELEVANCE – The extent to which the intervention objectives and design respond to the need of beneficiaries both regionally and globally and the alignment with iwCLL objectives.
FEASIBILITY – Practical feasibility of the intervention proposed with the available grant and duration of the project.
COHERENCE – The compatibility of the intervention with existing facilities/interventions in the region
EXCELLENCE – whether specific objectives of the project demonstrate excellence and originality, with a clear and well-developed rationale for engaging partners with appropriate skills from relevant disciplines and make a significant contribution to the advancement of the area.
EFFECTIVENESS – The extent to which the intervention is expected to achieve the objective, taking into account the relative importance of the objectives or results.
EFFICIENCY – The extent to which the intervention delivers, or is likely to deliver, results in an economical and timely way- Is the proposed intervention the most cost-effective way of delivering the objective/results.
IMPACT – The extent to which the intervention will make intended and unintended effects on the population it affects.
SUSTAINABILITY – The extent to which the net benefits of the intervention continue, or are likely to continue.
Application deadline: Monday 1 April 2024 at 23.59 CEST
Application review: April – May 2024
Decision: June 2024
Requirements for the successful applicant
Successful applicants agree to complete the training within one year of notification of the award.
In order to help measure program success, iwCLL Global Partnerships Subcommittee requires successful applicants to complete post-training reports at one month, six months, and one year after the end of the training.
The purpose of these follow-up reports is to:
- Measure the degree to which the participant was able to implement, at his/her home institution, the training received during his/her experience at the CLL Center.
- Evaluate the impact of the program on the participant’s professional career.
- Give the participant an opportunity to provide feedback on his/her personal experiences with the program.
- Allow the participant to express any issues that have arisen since returning to his/her home institution concerning the implementation of skills and procedures learned.
- The report should also contain an assessment by the host institution of the value of the training received by the candidate.
If you have questions relating to your application please contact the iwCLL Executive Office.
The successful applicant will be asked to enter into a funding agreement with iwCLL.